Effects of GHX02 on Chronic Obstructive Pulmonary Disease Mouse Model |
Yang, Won-Kyung
(Institute of Traditional Medicine and Bioscience, Daejeon University)
Lyu, Yee Ran (Division of Respiratory System, Dep. of Internal Medicine, College of Korean Medicine, Daejeon University) Kim, Seung-Hyung (Institute of Traditional Medicine and Bioscience, Daejeon University) Park, Yang Chun (Institute of Traditional Medicine and Bioscience, Daejeon University) |
1 | Kim V, Han MK, Vance GB, Make BJ, Newell JD, Hokanson JE, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest. 2011;140(3):626-33. DOI |
2 | Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. Journal of global health. 2015;5(2). |
3 | Gan WQ, FitzGerald JM, Carlsten C, Sadatsafavi M, Brauer M. Associations of ambient air pollution with chronic obstructive pulmonary disease hospitalization and mortality. American journal of respiratory and critical care medicine. 2013;187(7):721-7. DOI |
4 | Meijer M, Rijkers GT, Van Overveld FJ. Neutrophils and emerging targets for treatment in chronic obstructive pulmonary disease. Expert review of clinical immunology. 2013;9(11):1055-68. DOI |
5 | Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. The Journal of clinical investigation. 2008;118(11):3546-56. DOI |
6 | Prause O, Bossios A, Silverpil E, Ivanov S, Bozinovski S, Vlahos R, et al. IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar space after exposure to endotoxin from Escherichia coli in vivo-effects of anti-inflammatory pharmacotherapy. Pulmonary pharmacology & therapeutics. 2009;22(3):199-207. DOI |
7 | Caramori G, Adcock IM, Di Stefano A, Chung KF. Cytokine inhibition in the treatment of COPD. International journal of chronic obstructive pulmonary disease. 2014;9:397. |
8 | Van Minh C, Nhiem NX, Yen HT, Van Kiem P, Tai BH, Anh HLT, et al. Chemical constituents of Trichosanthes kirilowii and their cytotoxic activities. Archives of pharmacal research. 2015;38(8):1443-8. DOI |
9 | Spurzem JR, Rennard SI. Pathogenesis of COPD. in Seminars in respiratory and critical care medicine 2005. New York:Thieme Medical Publishers. c1994-. |
10 | Woodruff PG, Agusti A, Roche N, Singh D, Martinez FJ. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. The Lancet. 2015;385(9979):1789-98. DOI |
11 | Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology. 2016;138(1):16-27. DOI |
12 | Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. New England Journal of Medicine. 2009;360(23):2445-54. DOI |
13 | Oostwoud L, Gunasinghe P, Seow H, Ye J, Selemidis S, Bozinovski S, et al. Apocynin and ebselen reduce influenza A virus-induced lung inflammation in cigarette smoke-exposed mice. Scientific reports. 2016;6:20983. DOI |
14 | Kim HW, Yang SY, Kim MH, NamGung U, Park YC. Protective effects of Maekmundong-tang on elastase-induced lung injury. The Journal of Korean Medicine. 2011;32. |
15 | Chang HK, Yang HY, Lee TH, Shin MC, Lee MH, Shin MS, et al. Armeniacae semen extract suppresses lipopolysaccharide-induced expressions of cycloosygenase-2 and inducible nitric oxide synthase in mouse BV2 microglial cells. Biological and Pharmaceutical Bulletin. 2005;28(3):449-54. DOI |
16 | Yokozawa T, Ishida A, Cho EJ, Kim HY, Kashiwada Y, Ikeshiro Y. Coptidis Rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components. Journal of pharmacy and pharmacology. 2004;56(4):547-56. DOI |
17 | Kim JM, Jung HA, Choi JS, Lee NG. Identification of anti-inflammatory target genes of Rhizoma coptidis extract in lipopolysaccharide-stimulated RAW264. 7 murine macrophage-like cells. Journal of Ethnopharmacology. 2010;130(2):354-62. DOI |
18 | George J, Ioannides-Demos LL, Santamaria NM, Kong DC, Stewart K. Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease. Medical Journal of Australia. 2004;181(5):248. DOI |
19 | Lee ES, Han JM, Kim MH, Namgung U, Yeo Y, Park YC. Effects of Inhalable Microparticles of on Chronic Obstructive Pulmonary Disease in a Mouse Model. Journal of Korean Medicine. 2013;34(3):54-68. DOI |
20 | Lee H, Kim Y, Kim HJ, Park S, Jang YP, Jung S, et al. Herbal formula, PM014, attenuates lung inflammation in a murine model of chronic obstructive pulmonary disease. Evidence-Based Complementary and Alternative Medicine. 2012;2012. |
21 | Caramori G, Casolari P, Giuffre S, Barczyk A, Adcock I, Papi A. COPD pathology in the small airways. Panminerva medica. 2011;53(1):51-70. |
22 | Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. European Respiratory Journal. 2004;23(6):932-46. DOI |
23 | Donohue JF, Fogarty C, Lotvall J, Mahler DA, Worth H, Yorgancioglu A, et al. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. American journal of respiratory and critical care medicine. 2010;182(2):155-62. DOI |
24 | Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. The Lancet. 2009;373(9678):1905-17. DOI |
25 | Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. New England Journal of Medicine. 2007;356(8):775-89. DOI |
26 | Kim OS, Seo CS, Kim Y, Shin HK, Ha H. Extracts of Scutellariae Radix inhibit low-density lipoprotein oxidation and the lipopolysaccharide-induced macrophage inflammatory response. Molecular medicine reports. 2015;12(1):1335-41. DOI |
27 | Han JM, Yang WK, Kim SH, Park YC. Effects of Sagan-tang and individual herbs on COPD mice model. Herbal Formula Science. 2015;23(2):171-87. DOI |
28 | Lee CW, Yang WK, Lyu YR, Kim SH, Park YC. Effects of Gwaruhaengryeon-hwan on COPD and Particulate Matter Induced Lung Injury on a Mouse Model. The Journal of Internal Korean Medicine. 2017;38(3):353-66. DOI |
29 | Heo J. Dong-Ui-Bo-Gam. Hadong:Donguibogam Publish. 2005:1341. |
30 | Guo M, Zhang N, Li D, Liang D, Liu Z, Li F, et al. Baicalin plays an anti-inflammatory role through reducing nuclear and p38 phosphorylation in S. aureus-induced mastitis. International immunopharmacology. 2013;16(2):125-30. DOI |
31 | Gueders MM, Paulissen G, Crahay C, Quesada-Calvo F, Hacha J, Van Hove C, et al. Mouse models of asthma: a comparison between C57BL/6 and BALB/c strains regarding bronchial responsiveness, inflammation, and cytokine production. Inflammation research. 2009;58(12):845. DOI |
32 | Mizutani N, Fuchikami JI, Takahashi M, Nabe T, Yoshino S, Kohno S. Pulmonary emphysema induced by cigarette smoke solution and lipopolysaccharide in guinea pigs. Biological and Pharmaceutical Bulletin. 2009;32(9):1559-64. DOI |
33 | O'donnell R, Breen D, Wilson S, Djukanovic R. Inflammatory cells in the airways in COPD. Thorax. 2006;61(5):448-54. DOI |
34 | Tanaka H, Masuda T, Tokuoka S, Komai M, Nagao K, Takahashi Y, et al. The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflammation Research. 2001;50(12):616-24. DOI |